Fig. 5From: Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular eventsAnnual event rates for primary and secondary composite outcomes in patients with quantitative septal LGE above and below a 2.74 % threshold. Patients with septal LGE greater than 2.74 % had a significantly higher annual event rate than those without for the primary outcome (22.6 % versus 3.2 %, p < 0.0001), and secondary outcome (16.1 % versus 2.7 %, p < 0.0002). LGE = late gadolinium enhancementBack to article page